IMMUNOME INC COM is a security (CUSIP 45257U108) tracked across SEC portfolio filings. 194 institutional managers reported $2.1B on Form 13F as of 2026-06-30; 29 registered fund positions totaling $505.1M via N-PORT as of 2026-05-31.
Showing 15 of 194 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| FMR LLC | BOSTON, MA | $371.1M | 16,969,954 |
| BlackRock, Inc. | New York, NY | $178.6M | 8,168,674 |
| VANGUARD GROUP INC | Valley Forge, PA | $129.7M | 6,038,414 |
| Redmile Group, LLC | San Francisco, CA | $121.6M | 5,558,885 |
| STATE STREET CORP | BOSTON, MA | $118.1M | 5,399,901 |
| PRIMECAP MANAGEMENT CO/CA/ | PASADENA, CA | $104.7M | 4,788,231 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $103.5M | 4,731,977 |
| Driehaus Capital Management LLC | Chicago, IL | $89.7M | 4,099,901 |
| ENAVATE SCIENCES GP, LLC | New York, NY | $79.0M | 3,613,799 |
| MORGAN STANLEY | NEW YORK, NY | $62.1M | 2,841,589 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $56.0M | 2,560,664 |
| JPMORGAN CHASE & CO | NEW YORK, NY | $53.6M | 2,777,836 |
| Jefferies Financial Group Inc. | NEW YORK, NY | $50.8M | 1,160,715 |
| SILVERARC CAPITAL MANAGEMENT, LLC | BOSTON, MA | $40.5M | 1,850,278 |
| Sofinnova Investments, Inc. | Menlo Park, CA | $37.2M | 1,701,904 |
Showing 15 of 29 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. | T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | $126.1M | 156.22% |
| Fidelity Growth Company Fund | Fidelity Mt. Vernon Street Trust | $103.5M | 10.48% |
| T. Rowe Price Institutional Small-Cap Stock Fund | T. Rowe Price Equity Funds, Inc. | $68.2M | 157.35% |
| VANGUARD HEALTH CARE FUND | VANGUARD SPECIALIZED FUNDS | $63.7M | 17.28% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $36.4M | 33.44% |
| T. Rowe Price Small-Cap Value Fund, Inc. | T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | $35.4M | 38.37% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $25.3M | 3.10% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $11.4M | 6.53% |
| Fidelity Contrafund | Fidelity Contrafund | $8.8M | 0.56% |
| T. Rowe Price Spectrum Moderate Growth Allocation Fund | T. ROWE PRICE SPECTRUM FUNDS II, INC. | $4.5M | 10.39% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $3.6M | 7.52% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $2.8M | 2.19% |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VANGUARD WELLINGTON FUND | $2.8M | 15.17% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $2.3M | 35.44% |
| Optimum Small-Mid Cap Growth Fund | Optimum Fund Trust | $1.9M | 25.37% |